These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 22398037

  • 1. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
    Ji D, Liu Y, Li L, Xu Z, Si LL, Dai JZ, Li X, Wang L, Yao Z, Xin SJ, Chen GF, Xu D.
    J Clin Virol; 2012 May; 54(1):66-72. PubMed ID: 22398037
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
    Mirandola S, Sebastiani G, Rossi C, Velo E, Erne EM, Vario A, Tempesta D, Romualdi C, Campagnolo D, Alberti A.
    Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
    [Abstract] [Full Text] [Related]

  • 7. Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
    Moriconi F, Colombatto P, Coco B, Ciccorossi P, Oliveri F, Flichman D, Maina AM, Sacco R, Bonino F, Brunetto MR.
    J Antimicrob Chemother; 2007 Aug; 60(2):341-9. PubMed ID: 17567633
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
    Xu Z, Liu Y, Xu T, Chen L, Si L, Wang Y, Ren X, Zhong Y, Zhao J, Xu D.
    J Clin Virol; 2010 Aug; 48(4):270-4. PubMed ID: 20580309
    [Abstract] [Full Text] [Related]

  • 10. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
    Zhu Y, Curtis M, Borroto-Esoda K.
    Antivir Chem Chemother; 2011 Aug 23; 22(1):13-22. PubMed ID: 21860069
    [Abstract] [Full Text] [Related]

  • 11. Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs.
    Xiang KH, Zhao CY, Wang S, Li Y, Su MZ, Wang QY, Xu XZ, Deng J, Zhuang H, Li T.
    Antivir Ther; 2018 Aug 23; 23(1):33-42. PubMed ID: 28440785
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication.
    Billioud G, Pichoud C, Puerstinger G, Neyts J, Zoulim F.
    Antiviral Res; 2011 Nov 23; 92(2):271-6. PubMed ID: 21871497
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
    J Med Virol; 2007 Nov 23; 79(11):1664-70. PubMed ID: 17854034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K, Takehara T, Kato M, Deguchi M, Kagita M, Hikita H, Sasakawa A, Kohga K, Uemura A, Sakamori R, Yamaguchi S, Miyagi T, Ishida H, Tatsumi T, Hayashi N.
    J Infect Dis; 2008 Oct 15; 198(8):1150-8. PubMed ID: 18713056
    [Abstract] [Full Text] [Related]

  • 18. HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays.
    Zhu Y, Curtis M, Borroto-Esoda K.
    J Virol Methods; 2011 May 15; 173(2):340-6. PubMed ID: 21396961
    [Abstract] [Full Text] [Related]

  • 19. Association between lamivudine sensitivity and the number of substitutions in the reverse transcriptase region of the hepatitis B virus polymerase.
    Fukai K, Zhang KY, Imazeki F, Kurihara T, Mikata R, Yokosuka O.
    J Viral Hepat; 2007 Sep 15; 14(9):661-6. PubMed ID: 17697019
    [Abstract] [Full Text] [Related]

  • 20. [Mutations of HBV polymerase gene sequence in lamivudine-resistant chronic hepatitis B patients].
    Wang C, Sun J, Chen JJ, Wang ZH, Hou JL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 15; 28(5):729-30. PubMed ID: 18504191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.